| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |